Partnerships
Milagen has had many research and commercial partners over the years to advance our product line and introduce them to the market. Scroll down to learn more.
We are currently looking for like-minded investors and commercial partners to co-develop and commercialize our cancer tests. Please contact us below to start the discussion.
Select Partnerships
Milagen entered into partnerships with researchers from leading academic institutions and medical centers in order to advance the development of immunodiagnostic assays for early detection, prognosis and therapy management. These collaborations provided invaluable clinical expertise, unbiased feedback, and the chance for third-party validation of its products.
Laboratorios Columbia S.A. de C.V. & Major Mexican Hospitals
September 28, 2023
Laboratorios Columbia S.A. de C.V.
March 23, 2023
Uppsala University
March 30, 2018
The Instituto Nacional de Cancerología & Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
May 4, 2015
ServaCare
June 10, 2013
Laboratorios Grupo Columbia
April 18, 2011
MD Anderson Cancer Center, Houston, TX
May 24, 2004
University of California Los Angeles (UCLA)
April 15, 2004
University of California Los Angeles (UCLA)
November 24, 2003
National Cancer Institute (NCI)
November 21, 2003
Harvard School of Public Health
August 12, 2003
H. Lee Moffitt Cancer Center & University of South Florida
June 12, 2003